stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - PharmaCyte Biotech, Inc. | StockGist | StockGist
Companies
PMCB
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
PMCB
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
PharmaCyte Biotech, Inc.
Filed Feb 13, 2026
Accepted Feb 12, 2026, 7:00 PM ET
PMCB
CIK 0001157075
View on SEC.gov
Company Profile
0001213900-26-016526
Beneficial Ownership Report
Passive Investment
Shares Owned
532,254
Reporting Person
PharmaCyte Biotech, Inc.
Person Type
HC
CUSIP: 71715X203